Michael Irizarry

Michael Irizarry

UNVERIFIED PROFILE

Are you Michael Irizarry?   Register this Author

Register author
Michael Irizarry

Michael Irizarry

Publications by authors named "Michael Irizarry"

Are you Michael Irizarry?   Register this Author

65Publications

1098Reads

33Profile Views

Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.

Parkinsonism Relat Disord 2019 03 4;60:138-145. Epub 2018 Sep 4.

Memory and Aging Center, Department of Neurology, University of California, 675 Nelson Rising Lane, Suite 193, San Francisco, CA, 94158, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2018.08.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399076PMC
March 2019

Topographic staging of tau positron emission tomography images.

Alzheimers Dement (Amst) 2018 14;10:221-231. Epub 2018 Feb 14.

Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dadm.2018.01.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956800PMC
February 2018

Incidence of type 2 diabetes among patients exposed to the combination of pravastatin and paroxetine.

Curr Drug Saf 2015 ;10(2):152-8

Bristol-Myers Squibb Co., 311 Pennington-Rocky Hill Road, Pennington, NJ 08534, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1574886309666140527112907DOI Listing
February 2016

Prevalence, risk factors, clinical consequences, and treatment of enteral feed intolerance during critical illness.

JPEN J Parenter Enteral Nutr 2015 May 17;39(4):441-8. Epub 2014 Mar 17.

Department of Medicine and Public Health Sciences, Queen's University, Kingston, Ontario, Canada Clinical Evaluation Research Unit at Kingston General Hospital, Kingston, Ontario, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0148607114526450DOI Listing
May 2015

Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study.

Atherosclerosis 2014 Aug 22;235(2):384-91. Epub 2014 May 22.

WW Epidemiology, GlaxoSmithKline, Research Triangle Park, NC and Upper Merion, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2014.04.032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096578PMC
August 2014

Sudden unexpected death in epilepsy in lamotrigine randomized-controlled trials.

Epilepsia 2013 Jan 2;54(1):135-40. Epub 2012 Oct 2.

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1528-1167.2012.03689.xDOI Listing
January 2013

Risk of cancer in patients exposed to gabapentin in two electronic medical record systems.

Pharmacoepidemiol Drug Saf 2012 Feb 6;21(2):214-25. Epub 2011 Dec 6.

WW Epidemiology, GlaxoSmithKline, Research Triangle Park, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.2266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314779PMC
February 2012

Modeling Alzheimer's disease progression using the disease system analysis approach.

Alzheimers Dement 2012 Jan 22;8(1):39-50. Epub 2011 Jul 22.

Pharmacometrics, GlaxoSmithKline R&D, Upper Merion, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2010.12.012DOI Listing
January 2012

Risk factors for antiepileptic drug regimen change in patients with newly diagnosed epilepsy.

Epilepsy Behav 2011 Jun 30;21(2):168-72. Epub 2011 Apr 30.

Worldwide Epidemiology, GlaxoSmithKline, Middlesex, UK.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152550501100121
Publisher Site
http://dx.doi.org/10.1016/j.yebeh.2011.03.017DOI Listing
June 2011

Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers.

Alzheimer Dis Assoc Disord 2010 Jul-Sep;24(3):220-6

Memory Disorders Unit, Department of Neurology and Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital, Harvard Medical School, Boston , MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WAD.0b013e3181d61feaDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694274PMC
January 2011

Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration.

Exp Neurol 2010 Jun 24;223(2):657-61. Epub 2010 Feb 24.

MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00144886100006
Publisher Site
http://dx.doi.org/10.1016/j.expneurol.2010.02.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864327PMC
June 2010

Exploring differential prescribing between anti-epileptic drugs in epilepsy patients with a history of mood disorders.

Pharmacoepidemiol Drug Saf 2010 Mar;19(3):289-95

Department of Epidemiology, GlaxoSmithKline, Harlow, Essex CM19 5AW, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.1905DOI Listing
March 2010

Performance characteristics of plasma amyloid-beta 40 and 42 assays.

J Alzheimers Dis 2009 ;16(2):277-85

Division of Aging, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://www.medra.org/servlet/aliasResolver?alias=iospress&am
Publisher Site
http://dx.doi.org/10.3233/JAD-2009-0948DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737811PMC
June 2009

Plasma urate and progression of mild cognitive impairment.

Neurodegener Dis 2009 5;6(1-2):23-8. Epub 2008 Nov 5.

Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000170883DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745303PMC
February 2009

Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease.

Arch Neurol 2008 Jun;65(6):776-85

Massachusetts Alzheimer's Disease Research Center, Wang Ambulatory Care Center, Suite 720, Room 731-G, Massachusetts General Hospital, 15 Parkman St, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://archneur.jamanetwork.com/article.aspx?doi=10.1001/arc
Publisher Site
http://dx.doi.org/10.1001/archneur.65.6.776DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2662621PMC
June 2008

Shorter telomeres may mark early risk of dementia: preliminary analysis of 62 participants from the nurses' health study.

PLoS One 2008 Feb 13;3(2):e1590. Epub 2008 Feb 13.

Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001590PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2536511PMC
February 2008

The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease.

Neurosci Lett 2007 Nov 20;427(3):127-31. Epub 2007 Sep 20.

Department of Public Health/Geriatrics, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2007.09.023DOI Listing
November 2007

Expression of APP pathway mRNAs and proteins in Alzheimer's disease.

Brain Res 2007 Aug 5;1161:116-23. Epub 2007 Jun 5.

Alzheimer Disease Research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, MA 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brainres.2007.05.050DOI Listing
August 2007

Plasma Abeta levels do not reflect brain Abeta levels.

J Neuropathol Exp Neurol 2007 Apr;66(4):264-71

C. S. Kubik Laboratory for Neuropathology, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NEN.0b013e31803d3ae4DOI Listing
April 2007

Prospective study of plasma folate, vitamin B12, and cognitive function and decline.

Epidemiology 2006 Nov;17(6):650-7

Department of Medicine, Channing Laboratory, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ede.0000239727.59575.daDOI Listing
November 2006

Prevalence and effects of lobar microhemorrhages in early-stage dementia.

Neurodegener Dis 2005 ;2(6):305-12

Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000092317DOI Listing
October 2006

Coordinated expression of caspase 8, 3 and 7 mRNA in temporal cortex of Alzheimer disease: relationship to formic acid extractable abeta42 levels.

J Neuropathol Exp Neurol 2006 May;65(5):508-15

Alzheimer Research Unit, Mass General Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.jnen.0000229238.05748.12DOI Listing
May 2006

Relation of quantitative indexes of concurrent alpha-synuclein abnormalities to clinical outcome in autopsy-proven Alzheimer disease.

Arch Neurol 2006 Feb;63(2):226-30

Sergievsky Center, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archneur.63.2.226DOI Listing
February 2006

Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.

Exp Neurol 2005 Jul;194(1):91-6

Harvard Medical School, Massachusetts General Hospital, 114 16th Street, Charlestown, MA 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.expneurol.2005.01.026DOI Listing
July 2005

Autoantibodies to redox-modified oligomeric Abeta are attenuated in the plasma of Alzheimer's disease patients.

J Biol Chem 2005 Apr 21;280(17):17458-63. Epub 2005 Feb 21.

Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital and Harvard Medical School, Charlestown 02129-4404, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M414176200DOI Listing
April 2005

Nonsteroidal anti-inflammatory drugs lower Abeta42 and change presenilin 1 conformation.

Nat Med 2004 Oct 26;10(10):1065-6. Epub 2004 Sep 26.

Alzheimer Research Unit, Massachusetts General Hospital, 114 16th St, Charlestown, Massachusetts 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm1112DOI Listing
October 2004

Demonstration of BACE (beta-secretase) phosphorylation and its interaction with GGA1 in cells by fluorescence-lifetime imaging microscopy.

J Cell Sci 2004 Oct 5;117(Pt 22):5437-45. Epub 2004 Oct 5.

Alzheimer Disease Research Laboratory, Massachusetts General Hospital, Harvard Medical School, 114 16th Street, Charlestown, MA 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1242/jcs.01422DOI Listing
October 2004

Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein.

J Neurochem 2004 Sep;90(5):1132-43

Alzheimer Disease Research Unit, Massachusetts General Hospital-East, Charlestown, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1471-4159.2004.02581.xDOI Listing
September 2004

Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease.

Neurosci Lett 2004 Sep;367(2):228-31

Harvard Medical School, Massachusetts General Hospital, 114 16th Street, Charlestown, MA 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2004.06.011DOI Listing
September 2004

Biomarkers of Alzheimer disease in plasma.

NeuroRx 2004 Apr;1(2):226-34

Alzheimer Disease Research Unit, Department of Neurology, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC534932PMC
http://dx.doi.org/10.1602/neurorx.1.2.226DOI Listing
April 2004

Beta-secretase activity increases with aging in human, monkey, and mouse brain.

Am J Pathol 2004 Feb;164(2):719-25

Department of Neurology, Alzheimer Disease Research Unit, Massachusetts General Hospital-East, Charlestown, Massachusetts 02129, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1602259PMC
http://dx.doi.org/10.1016/s0002-9440(10)63159-8DOI Listing
February 2004

Genotyping of apolipoprotein E: comparative evaluation of different protocols.

Curr Protoc Hum Genet 2003 Nov;Chapter 9:Unit9.14

Harvard Medical School/Massachusetts General Hospital, Charlestown, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/0471142905.hg0914s38DOI Listing
November 2003

FGF-2 regulates neurogenesis and degeneration in the dentate gyrus after traumatic brain injury in mice.

J Clin Invest 2003 Oct;112(8):1202-10

Neuroscience Center, Radiology Department, Massachusetts General Hospital and Neuroscience Program, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI16618DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC213483PMC
October 2003

Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes.

J Cell Sci 2003 Aug 26;116(Pt 16):3339-46. Epub 2003 Jun 26.

Alzheimer Disease Research Laboratory, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1242/jcs.00643DOI Listing
August 2003

A turn of the sulfatide in Alzheimer's disease.

Ann Neurol 2003 Jul;54(1):7-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.10642DOI Listing
July 2003

Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels.

Arch Neurol 2003 Jul;60(7):958-64

Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archneur.60.7.958DOI Listing
July 2003

Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Abeta levels.

J Biol Chem 2002 Dec 15;277(50):48508-13. Epub 2002 Oct 15.

Alzheimer Research Unit, Massachusetts General Hospital, Charlestown 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M209085200DOI Listing
December 2002

Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease.

Arch Neurol 2002 Sep;59(9):1381-9

Alzheimer Disease Research Unit, Center for Aging, Genetics, and Neurodegeneration, Massachusetts General Hospital-East, Bldg 114, Room 2010, 114 16th Street, Charlestown, MA 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archneur.59.9.1381DOI Listing
September 2002

LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes.

Brain Res Mol Brain Res 2002 Jul;104(1):38-46

Alzheimer Research Unit, Department of Neurology, Massachusetts General Hospital, 114 16th Street, Room 2009, Charlestown, MA 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0169-328x(02)00203-6DOI Listing
July 2002